In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates

TY Tan, LSY Ng, E Tan, G Huang - Journal of antimicrobial …, 2007 - academic.oup.com
Objectives The study investigated the effect of colistin and minocycline when tested singly
and in combination against Acinetobacter baumannii. Methods Thirteen unrelated imipenem …

[HTML][HTML] Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan

S Begum, F Hasan, S Hussain… - Pakistan journal of …, 2013 - ncbi.nlm.nih.gov
Background & Objectives: Acinetobacter baumannii can cause a wide range of infections,
including bacteremia, pneumonia, urinary tract infection, peritonitis, etc. This organism is …

[HTML][HTML] Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India

N Taneja, G Singh, M Singh… - Indian Journal of Medical …, 2011 - journals.lww.com
complicated urinary tract infection (uTI) attending the Postgraduate Institute of Medical
Education and Research, Chandigarh, India, were included. Only first isolate from the …

Trend of extensively drug‐resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3‐year period

S Jasemi, M Douraghi, H Adibhesami… - Letters in applied …, 2016 - academic.oup.com
Comprehensive data on drug‐resistant patterns of Acinetobacter baumannii isolates in
developing countries is limited. We conducted a multihospital study to assess the rate and …

[HTML][HTML] Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report

JC Garcia Casallas, H Robayo-Amortegui… - Journal of Medical Case …, 2019 - Springer
Abstract Background Carbapenem-resistant Acinetobacter baumannii infections are a major
public health problem worldwide, requiring the use of “old” antibiotics such as polymyxin B …

[HTML][HTML] A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii …

B Boral, Ö Unaldi, A Ergin, R Durmaz… - Annals of clinical …, 2019 - Springer
Abstract Background Multidrug-resistant (MDR) Acinetobacter baumannii infections are
considered as emerging nosocomial infections particularly in patients hospitalized in …

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant …

KR Peck, MJ Kim, JY Choi, HS Kim… - Journal of medical …, 2012 - microbiologyresearch.org
The emergence of colistin or tigecycline resistance as well as imipenem resistance in
Acinetobacter baumannii poses a great therapeutic challenge. The bactericidal and …

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii

S Bae, MC Kim, SJ Park, HS Kim, H Sung… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Emerging resistance to colistin in clinical Acinetobacter baumannii isolates is of growing
concern. Since current treatment options for these strains are extremely limited, we …

Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates

P Kopterides, PK Koletsi, A Michalopoulos… - International journal of …, 2007 - Elsevier
In this study, we explored risk factors associated with bacteraemia caused by colistin-
susceptible/carbapenem-resistant (CoS/CaR) Acinetobacter baumannii. A retrospective …

[HTML][HTML] Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west …

SM Mortazavi, Z Farshadzadeh, S Janabadi… - New Microbes and New …, 2020 - Elsevier
Acinetobacter baumannii is one of the most important opportunistic challenging pathogens
as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety …